Hepatitis C virus (HCV)-related end-stage liver disease represents the primary indication for liver transplantation in Western countries, but is associated with poor posttransplantation outcomes and a rapid progression of HCV-related disease. This article reviews the risk factors underlying this association and presents the current strategies used to manage HCV infections in transplant recipients.

Angelico, M. (2011). Epidemiology and outcome of hepatitis C relapse in transplant recipients. TRANSPLANTATION PROCEEDINGS, 43(6), 2457-2458 [10.1016/j.transproceed.2011.06.016].

Epidemiology and outcome of hepatitis C relapse in transplant recipients

ANGELICO, MARIO
2011-01-01

Abstract

Hepatitis C virus (HCV)-related end-stage liver disease represents the primary indication for liver transplantation in Western countries, but is associated with poor posttransplantation outcomes and a rapid progression of HCV-related disease. This article reviews the risk factors underlying this association and presents the current strategies used to manage HCV infections in transplant recipients.
2011
Pubblicato
Rilevanza internazionale
Articolo
Sì, ma tipo non specificato
Settore MED/12 - GASTROENTEROLOGIA
English
Con Impact Factor ISI
Antiviral Agents; End Stage Liver Disease; Hepatitis C; Humans; Recurrence; Risk Assessment; Risk Factors; Treatment Outcome; Liver Transplantation
Angelico, M. (2011). Epidemiology and outcome of hepatitis C relapse in transplant recipients. TRANSPLANTATION PROCEEDINGS, 43(6), 2457-2458 [10.1016/j.transproceed.2011.06.016].
Angelico, M
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/119444
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 4
social impact